About this trial
The purpose of this observational study is to understand how adults who survive acute respiratory failure (ARF) and the people (usually family) who support ARF survivors after returning home think about the first 6 months of recovery. The study aims to find out if expectations about the recovery process after ARF are associated with mental health symptoms in both survivors and the survivor's care partners. Study participants will complete 3 surveys over 6 months. These surveys ask questions about participants' future expectations, feelings, and mood. Surveys can be completed online, over the phone, or on paper.
Eligibility criteria
Qualifiers
≥18 years old
Mechanical ventilation via an endotracheal tube ≥24 consecutive hours OR
Non-invasive ventilation (CPAP, BiPAP) ≥24 consecutive hours that is not for obstructive sleep apnea or other stable use OR
High flow nasal cannula with fraction of inspired oxygen (FIO2)≥.5 and flow rate ≥ litres per minute (LPM) for ≥24 consecutive hours.
Disqualifiers
Pre-existing cognitive impairment (IQ-CODE >3.6)
Residing in a medical institution at hospital discharge
Receiving hospice care or life expectancy <6 months
Homelessness or recent history of psychosis
Trial design
Treatments tested in this trial
- Dyadic expectations about the ARF survivor's perceived health 6 months after hospital discharge
- Self-efficacy
- Concordant expectations/shared appraisal of ARF survivor's health 6 months after hospital discharge
Treatment groups
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator